These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2183732)

  • 1. Outpatient management of uncomplicated lower-extremity infections in diabetic patients.
    Lipsky BA; Pecoraro RE; Larson SA; Hanley ME; Ahroni JH
    Arch Intern Med; 1990 Apr; 150(4):790-7. PubMed ID: 2183732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
    Raja NS
    J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
    Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
    Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diabetic foot. Soft tissue and bone infection.
    Lipsky BA; Pecoraro RE; Wheat LJ
    Infect Dis Clin North Am; 1990 Sep; 4(3):409-32. PubMed ID: 2212597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections.
    Gall SA; Kohan AP; Ayers OM; Hughes CE; Addison WA; Hill GB
    Obstet Gynecol; 1981 Jan; 57(1):51-8. PubMed ID: 7005778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
    Lobmann R; Ambrosch A; Seewald M; Dietlein M; Zink K; Kullmann KH; Lehnert H
    Diabetes Nutr Metab; 2004 Jun; 17(3):156-62. PubMed ID: 15334793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic therapy in the treatment of inflammatory diseases in the minor pelvis].
    Vasiljević M; Marković A; Ganović R; Jovanović R
    Srp Arh Celok Lek; 1996; 124(7-8):193-6. PubMed ID: 9102846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients.
    Viswanathan V; Jasmine JJ; Snehalatha C; Ramachandran A
    J Assoc Physicians India; 2002 Aug; 50():1013-6. PubMed ID: 12421021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiology and antimicrobial therapy of diabetic foot infections.
    Joseph WS; Axler DA
    Clin Podiatr Med Surg; 1990 Jul; 7(3):467-81. PubMed ID: 2205347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic foot infections. Bacteriologic analysis.
    Wheat LJ; Allen SD; Henry M; Kernek CB; Siders JA; Kuebler T; Fineberg N; Norton J
    Arch Intern Med; 1986 Oct; 146(10):1935-40. PubMed ID: 3767539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic foot infection.
    Bader MS
    Am Fam Physician; 2008 Jul; 78(1):71-9. PubMed ID: 18649613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic therapy in the infected diabetic foot].
    Vieru A; Mazilu G; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1091-6. PubMed ID: 22276452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral clindamycin and ciprofloxacin therapy for diabetic foot infections.
    Sesin GP; Paszko A; O'Keefe E
    Pharmacotherapy; 1990; 10(2):154-6. PubMed ID: 2190194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Lesse AJ; Freer C; Salata RA; Francis JB; Scheld WM
    Am J Med; 1987 Apr; 82(4A):247-53. PubMed ID: 3555043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriology of diabetic foot ulcers.
    Ramani A; Ramani R; Shivananda PG; Kundaje GN
    Indian J Pathol Microbiol; 1991 Apr; 34(2):81-7. PubMed ID: 1752646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime.
    Hughes CE; Johnson CC; Bamberger DM; Reinhardt JF; Peterson LR; Mulligan ME; Gerding DN; George WL; Finegold SM
    Clin Ther; 1987; 10 Suppl A():36-49. PubMed ID: 3319172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of infections caused by anaerobes.
    Wilson WR
    J Chemother; 1991 Feb; 3 Suppl 2():7-11. PubMed ID: 2040901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.